Indian firms report mixed Q2 earnings as Max Healthcare profit falls and Sun Pharma sees revenue rise

सारांश

Max Healthcare posted a 15.5% drop in net profit while Sun Pharmaceutical posted higher revenue but lower profit, amid varied performance across several Indian companies in the quarter.

Max Healthcare announced a 15.5% year-on-year decline in net profit to Rs 415 crore for the second quarter, while revenue grew 20.3% to Rs 2,569 crore and EBITDA rose 23.8% to Rs 712 crore, improving the EBITDA margin to 27.7%. The company approved a capital expenditure plan of Rs 190 crore for two hospitals and revised the cost of its Gurugram facility to Rs 1,143 crore.

Sun Pharmaceutical Industries reported a 36.2% year-on-year fall in net profit to Rs 1,989 crore, reflecting a one-time loss of Rs 1,269 crore. Revenue increased 11.9% to Rs 16,199 crore, surpassing estimates, and EBITDA rose 4.8% to Rs 4,744 crore, with the margin expanding to 29.3%.

InterGlobe Aviation, operator of IndiGo, narrowed its quarterly loss to Rs 1,879 crore from Rs 2,582 crore a year earlier, as revenue jumped 25.9% to Rs 23,364 crore. EBITDA improved to Rs 1,908 crore and the EBITDA margin rose to 8.2%.

Kirloskar Ferrous Industries posted an 18.5% quarter-on-quarter increase in net profit to Rs 97.5 crore, with revenue up 15.6% to Rs 2,047 crore, though the EBITDA margin fell to 10.9%.

Varun Beverages reported a 13.7% year-on-year rise in net profit to Rs 828 crore, beating estimates, as revenue climbed 33.3% to Rs 6,816 crore.

Analysts noted that margin pressure remains a concern across sectors, citing weaker mobile volumes and input-cost inflation in the first quarter. Expectations for the upcoming quarter include monitoring mobile volume performance, market-share gains, and the impact of lower industry volumes on profitability.

स्रोत

NDTV Profit

पढ़ते रहें — निःशुल्क

समाचार फ़ॉलो करने के लिए मुफ़्त खाता बनाएँ। कार्ड की आवश्यकता नहीं।